On May 21st, 2019, the RSNN organized an ‘Expert Meeting’ on the topic of pharmaceutical compounding. As in many countries, there is a lively debate in the...
Read more
Report
25 July 2019
RSNN Annual Report 2018 - Public Summary
2018 has been a year of expansion and consolidation for the RSNN. The number of RSNN members and partner organization has grown, as well as the number of...
Read more
Report
24 July 2019
RSNN responds to EMA’s draft strategy ‘Regulatory Science to 2025’
The RSNN is very excited about the draft strategy and foresees significant contributions to innovating and improving regulatory science.
Read more
Report
15 July 2019
Innovating clinical trials: a rich menu of options in which early dialogue will identify acceptable and feasible approaches
RSNN – Workshop 2019 – Key Takeaways
Read more
Report
28 November 2018
Regulatory challenges for the next wave of cancer therapies
In the RSNN morning session of the FIGON Dutch Medicines Days speakers from different perspectives presented their views on the challenges that come with...
Read more
Report
28 November 2018
Evidence generation for innovative products in oncology
In the RSNN afternoon session of the FIGON Dutch Medicines Days, future evidence generation strategies were discussed.
Regulatory Science Network Netherlands
